Ask the Expert: Diana Isaacs on Benefits, Risks, and Real-World Use of GLP-1s in T1D
GLP-1 receptor agonists like Ozempic (semaglutide) and tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) have gained traction in diabetes care, including use in…
Understanding Time in Range, GMI, and A1C in Type 1 Diabetes
Move over A1C? Well, not so fast. While we rely more and more on data points from wearable continuous glucose monitors (CGMs)…
Ayla Kanow’s Story: Climbing Mt. Whitney with Type 1 Diabetes (Twice)
Standing on the top of Mt. Whitney felt different this time. The high alpine sun still kissed the High Sierra…
Teamwork, Targets, Technology, and Tight Range (4T) in New-Onset T1D: Comparing Outcomes and Rationale for Translation
Alonso, G.T, Thapa, S, Maahs, D, Wolf, R, Bishop, F, DeSalvo, D, Addala, A, Prahalad, P, Mann, E, Jacobsen, L,…
Time-in-Range: Making the Most of Your CGM Data
Disclaimer: T1D Exchange and the author are not medical professionals. Your target time-in-range may be tailored to your current needs…
